aap Implantate AG

XETRA AAQ1.DE

aap Implantate AG Price to Earnings Ratio (P/E) on February 03, 2025: -4.11

aap Implantate AG Price to Earnings Ratio (P/E) is -4.11 on February 03, 2025, a -116.59% change year over year. Price to earnings ratio compares the stock price to earnings per share; higher P/E suggests expectations for future earnings growth.

aap Implantate AG 52-week high Price to Earnings Ratio (P/E) is -1.90 on February 05, 2024, which is 53.83% above the current Price to Earnings Ratio (P/E).
aap Implantate AG 52-week low Price to Earnings Ratio (P/E) is -8.20 on October 15, 2024, which is -99.61% below the current Price to Earnings Ratio (P/E).
aap Implantate AG average Price to Earnings Ratio (P/E) for the last 52 weeks is -3.65.

Key data

Date	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield

XETRA: AAQ1.DE

aap Implantate AG

CEO	Mr. Rubino Di Girolamo
IPO Date	May 11, 1999
Location	Germany
Headquarters	Lorenzweg 5
Employees	87
Sector	Healthcare
Industries Medical Instruments 3D Printing Automotive Parts Composite Materials Glass Hardware & Electronics Pharmaceuticals Plastics

Description

aap Implantate AG, a medical device company, develops, manufactures, and markets trauma products for orthopedics in Germany, the United States, and internationally. It offers LOQTEQ, an anatomical plating system for fracture treatment; and a range of cannulated screws, standard plates, and screws. The company sells its products directly to hospitals, buying syndicates, and hospital groups, as well as through a network of distributors under the aap brand name. aap Implantate AG was founded in 1990 and is headquartered in Berlin, Germany.

Key trends

Past 5 years